Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How the American Heart Association Focuses on the Entire Cardiovascular System

This week on I Don’t Care with Kevin Stevenson, he sits down with Michelle Stoddard and Dr. Abe DeAnda to discuss how the American Heart Association goes past just cardiac care and how the organization aims to work closely within their local communities. While the heart may be at the well, heart of what…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

This week on I Don’t Care with Kevin Stevenson, he sits down with Michelle Stoddard and Dr. Abe DeAnda to discuss how the American Heart Association goes past just cardiac care and how the organization aims to work closely within their local communities.

While the heart may be at the well, heart of what the American Heart Association does, this prestigious pillar of the medical pillar works tirelessly to protect so much more than our hearts. According to Dr. Abe DeAnda, Professor and Chief, Cardiovascular and Thoracic Surgery at the American Heart Association at UTMB in Galveston, the research they do at the American Heart Association benefits the entire body. “It’s not just the heart, it’s cardiovascular. So it’s your vessels, including your cerebral vascular vessels. So every bit of research that occurs, is going to be anything that has a blood vessel, alright so not just your heart,” Dr. DeAnda said.

He went on to explain that the heart affects the aorta, peripheral vascular system, legs, kidneys, essentially everything in the body. “When you have claudication, when it hurts to walk, or you have poor perfusion. It’s going to be your kidneys, when you’re not getting enough blood to your kidneys, it’s gonna be your brain when you have a stroke or you have some type of other cerebrovascular disease,” Dr. DeAnda explained.

Another image associated with the name of the association is that they do work that is felt only on a domestic level, but their work truly does have a global impact. “So if you can imagine an organization that’s funding that, it’s a big organization, right. It has to be, it’s your whole body and it’s dealing with the diseases that kill a lot of people in this country and worldwide. The other, I don’t want to really call it a misnomer, but the American part, this is worldwide. This is international,” Dr. DeAnda stated.

Catch up on previous episodes of I Don’t Care with Kevin Stevenson!

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512